The Food and Drug Administration (FDA) approved the first rapid response novel coronavirus (COVID-19) test that drastically decreases wait time for results.
Manufactured by California-based company Cepheid , the test can detect the virus in approximately 45 minutes, so patients will no longer have to wait days to get results back from labs.
Shipping will reportedly begin next week, although it's unclear which health care facilities will be getting them, or how many.
Dr. David Persing, MD, Ph.D., chief medical and technology officer at Cepheid, is calling the new test transformative.
"[The test can] help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities that need to properly allocate their respiratory isolation resources," he said.
Click here to sign up for Daily Voice's free daily emails and news alerts.